Product
C-peptide
2 clinical trials
2 indications
Indication
Type 1 DiabetesIndication
HypoglycemiaClinical trial
Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control IndividualsStatus: Not yet recruiting, Estimated PCD: 2026-08-01
Clinical trial
On the Regulation of Hepatic Glucose Metabolism During Insulin-induced HypoglycemiaStatus: Active (not recruiting), Estimated PCD: 2027-06-01